EBV	B:C0014644
MicroRNA	O
BART16	I:C1101610
Suppresses	O
Type	O
I	I:C2610474
IFN	I:C2610474
Signaling	I:C2610474
Type	O
I	I:C0021743
IFNs	I:C0021743
play	O
critical	O
roles	O
in	O
orchestrating	O
the	O
antiviral	O
defense	I:C1155328
by	O
inducing	O
direct	O
antiviral	O
activities	I:C1155328
and	O
shaping	O
the	O
adaptive	O
immune	I:C1749719
response	I:C1749719
.	O

EBV	O
MicroRNA	B:C1101610
BART16	I:C1101610
Suppresses	O
Type	O
I	I:C2610474
IFN	I:C2610474
Signaling	I:C2610474
Type	O
I	I:C0021743
IFNs	I:C0021743
play	O
critical	O
roles	O
in	O
orchestrating	O
the	O
antiviral	O
defense	I:C1155328
by	O
inducing	O
direct	O
antiviral	O
activities	I:C1155328
and	O
shaping	O
the	O
adaptive	O
immune	I:C1749719
response	I:C1749719
.	O

EBV	O
MicroRNA	O
BART16	I:C1101610
Suppresses	O
Type	B:C2610474
I	I:C2610474
IFN	I:C2610474
Signaling	I:C2610474
Type	O
I	I:C0021743
IFNs	I:C0021743
play	O
critical	O
roles	O
in	O
orchestrating	O
the	O
antiviral	O
defense	I:C1155328
by	O
inducing	O
direct	O
antiviral	O
activities	I:C1155328
and	O
shaping	O
the	O
adaptive	O
immune	I:C1749719
response	I:C1749719
.	O

EBV	O
MicroRNA	O
BART16	I:C1101610
Suppresses	O
Type	O
I	I:C2610474
IFN	I:C2610474
Signaling	I:C2610474
Type	B:C0021743
I	I:C0021743
IFNs	I:C0021743
play	O
critical	O
roles	O
in	O
orchestrating	O
the	O
antiviral	O
defense	I:C1155328
by	O
inducing	O
direct	O
antiviral	O
activities	I:C1155328
and	O
shaping	O
the	O
adaptive	O
immune	I:C1749719
response	I:C1749719
.	O

EBV	O
MicroRNA	O
BART16	I:C1101610
Suppresses	O
Type	O
I	I:C2610474
IFN	I:C2610474
Signaling	I:C2610474
Type	O
I	I:C0021743
IFNs	I:C0021743
play	O
critical	O
roles	O
in	O
orchestrating	O
the	O
antiviral	B:C1155328
defense	I:C1155328
by	O
inducing	O
direct	O
antiviral	O
activities	I:C1155328
and	O
shaping	O
the	O
adaptive	O
immune	I:C1749719
response	I:C1749719
.	O

EBV	O
MicroRNA	O
BART16	I:C1101610
Suppresses	O
Type	O
I	I:C2610474
IFN	I:C2610474
Signaling	I:C2610474
Type	O
I	I:C0021743
IFNs	I:C0021743
play	O
critical	O
roles	O
in	O
orchestrating	O
the	O
antiviral	O
defense	I:C1155328
by	O
inducing	O
direct	O
antiviral	B:C1155328
activities	I:C1155328
and	O
shaping	O
the	O
adaptive	O
immune	I:C1749719
response	I:C1749719
.	O

EBV	O
MicroRNA	O
BART16	I:C1101610
Suppresses	O
Type	O
I	I:C2610474
IFN	I:C2610474
Signaling	I:C2610474
Type	O
I	I:C0021743
IFNs	I:C0021743
play	O
critical	O
roles	O
in	O
orchestrating	O
the	O
antiviral	O
defense	I:C1155328
by	O
inducing	O
direct	O
antiviral	O
activities	I:C1155328
and	O
shaping	B:C0332479
the	O
adaptive	O
immune	I:C1749719
response	I:C1749719
.	O

EBV	O
MicroRNA	O
BART16	I:C1101610
Suppresses	O
Type	O
I	I:C2610474
IFN	I:C2610474
Signaling	I:C2610474
Type	O
I	I:C0021743
IFNs	I:C0021743
play	O
critical	O
roles	O
in	O
orchestrating	O
the	O
antiviral	O
defense	I:C1155328
by	O
inducing	O
direct	O
antiviral	O
activities	I:C1155328
and	O
shaping	O
the	O
adaptive	B:C1749719
immune	I:C1749719
response	I:C1749719
.	O

Viruses	B:C0042776
have	O
evolved	O
numerous	O
strategies	O
to	O
specifically	O
interfere	O
with	O
IFN	O
production	I:C1819430
or	O
its	O
downstream	O
mediators	I:C0021054
,	O
thereby	O
allowing	O
successful	O
infection	O
of	O
the	O
host	O
to	O
occur	O
.	O

Viruses	O
have	O
evolved	O
numerous	O
strategies	O
to	O
specifically	O
interfere	O
with	O
IFN	B:C1819430
production	I:C1819430
or	O
its	O
downstream	O
mediators	I:C0021054
,	O
thereby	O
allowing	O
successful	O
infection	O
of	O
the	O
host	O
to	O
occur	O
.	O

Viruses	O
have	O
evolved	O
numerous	O
strategies	O
to	O
specifically	O
interfere	O
with	O
IFN	O
production	I:C1819430
or	O
its	O
downstream	B:C0021054
mediators	I:C0021054
,	O
thereby	O
allowing	O
successful	O
infection	O
of	O
the	O
host	O
to	O
occur	O
.	O

Viruses	O
have	O
evolved	O
numerous	O
strategies	O
to	O
specifically	O
interfere	O
with	O
IFN	O
production	I:C1819430
or	O
its	O
downstream	O
mediators	I:C0021054
,	O
thereby	O
allowing	O
successful	O
infection	B:C3714514
of	O
the	O
host	O
to	O
occur	O
.	O

The	O
prototypic	O
human	O
gammaherpesvirus	O
EBV	B:C0014644
,	O
which	O
is	O
associated	O
with	O
infectious	O
mononucleosis	I:C0021345
and	O
malignant	O
tumors	I:C0006826
,	O
harbors	O
many	O
immune	O
-	I:C1654934
evasion	I:C1654934
proteins	O
that	O
manipulate	O
the	O
adaptive	O
and	O
innate	O
immune	O
systems	I:C0020962
.	O

The	O
prototypic	O
human	O
gammaherpesvirus	O
EBV	O
,	O
which	O
is	O
associated	O
with	O
infectious	B:C0021345
mononucleosis	I:C0021345
and	O
malignant	O
tumors	I:C0006826
,	O
harbors	O
many	O
immune	O
-	I:C1654934
evasion	I:C1654934
proteins	O
that	O
manipulate	O
the	O
adaptive	O
and	O
innate	O
immune	O
systems	I:C0020962
.	O

The	O
prototypic	O
human	O
gammaherpesvirus	O
EBV	O
,	O
which	O
is	O
associated	O
with	O
infectious	O
mononucleosis	I:C0021345
and	O
malignant	B:C0006826
tumors	I:C0006826
,	O
harbors	O
many	O
immune	O
-	I:C1654934
evasion	I:C1654934
proteins	O
that	O
manipulate	O
the	O
adaptive	O
and	O
innate	O
immune	O
systems	I:C0020962
.	O

The	O
prototypic	O
human	O
gammaherpesvirus	O
EBV	O
,	O
which	O
is	O
associated	O
with	O
infectious	O
mononucleosis	I:C0021345
and	O
malignant	O
tumors	I:C0006826
,	O
harbors	O
many	O
immune	B:C1654934
-	I:C1654934
evasion	I:C1654934
proteins	O
that	O
manipulate	O
the	O
adaptive	O
and	O
innate	O
immune	O
systems	I:C0020962
.	O

The	O
prototypic	O
human	O
gammaherpesvirus	O
EBV	O
,	O
which	O
is	O
associated	O
with	O
infectious	O
mononucleosis	I:C0021345
and	O
malignant	O
tumors	I:C0006826
,	O
harbors	O
many	O
immune	O
-	I:C1654934
evasion	I:C1654934
proteins	B:C0033684
that	O
manipulate	O
the	O
adaptive	O
and	O
innate	O
immune	O
systems	I:C0020962
.	O

The	O
prototypic	O
human	O
gammaherpesvirus	O
EBV	O
,	O
which	O
is	O
associated	O
with	O
infectious	O
mononucleosis	I:C0021345
and	O
malignant	O
tumors	I:C0006826
,	O
harbors	O
many	O
immune	O
-	I:C1654934
evasion	I:C1654934
proteins	O
that	O
manipulate	O
the	O
adaptive	B:C0678209
and	O
innate	O
immune	O
systems	I:C0020962
.	O

The	O
prototypic	O
human	O
gammaherpesvirus	O
EBV	O
,	O
which	O
is	O
associated	O
with	O
infectious	O
mononucleosis	I:C0021345
and	O
malignant	O
tumors	I:C0006826
,	O
harbors	O
many	O
immune	O
-	I:C1654934
evasion	I:C1654934
proteins	O
that	O
manipulate	O
the	O
adaptive	O
and	O
innate	O
immune	B:C0020962
systems	I:C0020962
.	O

In	O
addition	O
to	O
proteins	B:C0033684
,	O
the	O
virus	O
encodes	O
>	O
40	O
mature	O
microRNAs	O
for	O
which	O
the	O
functions	O
remain	O
largely	O
unknown	O
.	O

In	O
addition	O
to	O
proteins	O
,	O
the	O
virus	B:C0042776
encodes	O
>	O
40	O
mature	O
microRNAs	O
for	O
which	O
the	O
functions	O
remain	O
largely	O
unknown	O
.	O

In	O
addition	O
to	O
proteins	O
,	O
the	O
virus	O
encodes	O
>	O
40	O
mature	O
microRNAs	B:C1101610
for	O
which	O
the	O
functions	O
remain	O
largely	O
unknown	O
.	O

In	O
this	O
article	O
,	O
we	O
identify	O
EBV	B:C0014644
-	O
encoded	O
miR-BART16	O
as	O
a	O
novel	O
viral	O
immune	O
-	I:C1654934
evasion	I:C1654934
factor	O
that	O
interferes	O
with	O
the	O
type	O
I	I:C2610474
IFN	I:C2610474
signaling	I:C2610474
pathway	I:C2610474
.	O

In	O
this	O
article	O
,	O
we	O
identify	O
EBV	O
-	O
encoded	O
miR-BART16	B:C1101610
as	O
a	O
novel	O
viral	O
immune	O
-	I:C1654934
evasion	I:C1654934
factor	O
that	O
interferes	O
with	O
the	O
type	O
I	I:C2610474
IFN	I:C2610474
signaling	I:C2610474
pathway	I:C2610474
.	O

In	O
this	O
article	O
,	O
we	O
identify	O
EBV	O
-	O
encoded	O
miR-BART16	O
as	O
a	O
novel	O
viral	O
immune	B:C1654934
-	I:C1654934
evasion	I:C1654934
factor	O
that	O
interferes	O
with	O
the	O
type	O
I	I:C2610474
IFN	I:C2610474
signaling	I:C2610474
pathway	I:C2610474
.	O

In	O
this	O
article	O
,	O
we	O
identify	O
EBV	O
-	O
encoded	O
miR-BART16	O
as	O
a	O
novel	O
viral	O
immune	O
-	I:C1654934
evasion	I:C1654934
factor	O
that	O
interferes	O
with	O
the	O
type	B:C2610474
I	I:C2610474
IFN	I:C2610474
signaling	I:C2610474
pathway	I:C2610474
.	O

miR-BART16	B:C1101610
directly	O
targets	O
CREB	O
-	I:C0256079
binding	I:C0256079
protein	I:C0256079
,	O
a	O
key	O
transcriptional	O
coactivator	I:C1336776
in	O
IFN	O
signaling	I:C1512827
,	O
thereby	O
inducing	O
CREB	O
-	I:C0256079
binding	I:C0256079
protein	I:C0256079
downregulation	O
in	O
EBV	O
-	I:C2699839
transformed	I:C2699839
B	I:C2699839
cells	I:C2699839
and	O
gastric	O
carcinoma	I:C1333789
cells	I:C1333789
.	O

miR-BART16	O
directly	O
targets	O
CREB	B:C0256079
-	I:C0256079
binding	I:C0256079
protein	I:C0256079
,	O
a	O
key	O
transcriptional	O
coactivator	I:C1336776
in	O
IFN	O
signaling	I:C1512827
,	O
thereby	O
inducing	O
CREB	O
-	I:C0256079
binding	I:C0256079
protein	I:C0256079
downregulation	O
in	O
EBV	O
-	I:C2699839
transformed	I:C2699839
B	I:C2699839
cells	I:C2699839
and	O
gastric	O
carcinoma	I:C1333789
cells	I:C1333789
.	O

miR-BART16	O
directly	O
targets	O
CREB	O
-	I:C0256079
binding	I:C0256079
protein	I:C0256079
,	O
a	O
key	O
transcriptional	B:C1336776
coactivator	I:C1336776
in	O
IFN	O
signaling	I:C1512827
,	O
thereby	O
inducing	O
CREB	O
-	I:C0256079
binding	I:C0256079
protein	I:C0256079
downregulation	O
in	O
EBV	O
-	I:C2699839
transformed	I:C2699839
B	I:C2699839
cells	I:C2699839
and	O
gastric	O
carcinoma	I:C1333789
cells	I:C1333789
.	O

miR-BART16	O
directly	O
targets	O
CREB	O
-	I:C0256079
binding	I:C0256079
protein	I:C0256079
,	O
a	O
key	O
transcriptional	O
coactivator	I:C1336776
in	O
IFN	B:C1512827
signaling	I:C1512827
,	O
thereby	O
inducing	O
CREB	O
-	I:C0256079
binding	I:C0256079
protein	I:C0256079
downregulation	O
in	O
EBV	O
-	I:C2699839
transformed	I:C2699839
B	I:C2699839
cells	I:C2699839
and	O
gastric	O
carcinoma	I:C1333789
cells	I:C1333789
.	O

miR-BART16	O
directly	O
targets	O
CREB	O
-	I:C0256079
binding	I:C0256079
protein	I:C0256079
,	O
a	O
key	O
transcriptional	O
coactivator	I:C1336776
in	O
IFN	O
signaling	I:C1512827
,	O
thereby	O
inducing	O
CREB	B:C0256079
-	I:C0256079
binding	I:C0256079
protein	I:C0256079
downregulation	O
in	O
EBV	O
-	I:C2699839
transformed	I:C2699839
B	I:C2699839
cells	I:C2699839
and	O
gastric	O
carcinoma	I:C1333789
cells	I:C1333789
.	O

miR-BART16	O
directly	O
targets	O
CREB	O
-	I:C0256079
binding	I:C0256079
protein	I:C0256079
,	O
a	O
key	O
transcriptional	O
coactivator	I:C1336776
in	O
IFN	O
signaling	I:C1512827
,	O
thereby	O
inducing	O
CREB	O
-	I:C0256079
binding	I:C0256079
protein	I:C0256079
downregulation	B:C0013081
in	O
EBV	O
-	I:C2699839
transformed	I:C2699839
B	I:C2699839
cells	I:C2699839
and	O
gastric	O
carcinoma	I:C1333789
cells	I:C1333789
.	O

miR-BART16	O
directly	O
targets	O
CREB	O
-	I:C0256079
binding	I:C0256079
protein	I:C0256079
,	O
a	O
key	O
transcriptional	O
coactivator	I:C1336776
in	O
IFN	O
signaling	I:C1512827
,	O
thereby	O
inducing	O
CREB	O
-	I:C0256079
binding	I:C0256079
protein	I:C0256079
downregulation	O
in	O
EBV	B:C2699839
-	I:C2699839
transformed	I:C2699839
B	I:C2699839
cells	I:C2699839
and	O
gastric	O
carcinoma	I:C1333789
cells	I:C1333789
.	O

miR-BART16	O
directly	O
targets	O
CREB	O
-	I:C0256079
binding	I:C0256079
protein	I:C0256079
,	O
a	O
key	O
transcriptional	O
coactivator	I:C1336776
in	O
IFN	O
signaling	I:C1512827
,	O
thereby	O
inducing	O
CREB	O
-	I:C0256079
binding	I:C0256079
protein	I:C0256079
downregulation	O
in	O
EBV	O
-	I:C2699839
transformed	I:C2699839
B	I:C2699839
cells	I:C2699839
and	O
gastric	B:C1333789
carcinoma	I:C1333789
cells	I:C1333789
.	O

miR-BART16	B:C1101610
abrogates	O
the	O
production	O
of	O
IFN	O
-	O
stimulated	O
genes	O
in	O
response	O
to	O
IFN	O
-α	I:C0002199
stimulation	O
and	O
it	O
inhibits	O
the	O
antiproliferative	O
effect	O
of	O
IFN	O
-α	I:C0002199
on	O
latently	O
infected	O
BL	O
cells	I:C0004561
.	O

miR-BART16	O
abrogates	O
the	O
production	O
of	O
IFN	B:C0021747
-	O
stimulated	O
genes	O
in	O
response	O
to	O
IFN	O
-α	I:C0002199
stimulation	O
and	O
it	O
inhibits	O
the	O
antiproliferative	O
effect	O
of	O
IFN	O
-α	I:C0002199
on	O
latently	O
infected	O
BL	O
cells	I:C0004561
.	O

miR-BART16	O
abrogates	O
the	O
production	O
of	O
IFN	O
-	O
stimulated	B:C0038337
genes	O
in	O
response	O
to	O
IFN	O
-α	I:C0002199
stimulation	O
and	O
it	O
inhibits	O
the	O
antiproliferative	O
effect	O
of	O
IFN	O
-α	I:C0002199
on	O
latently	O
infected	O
BL	O
cells	I:C0004561
.	O

miR-BART16	O
abrogates	O
the	O
production	O
of	O
IFN	O
-	O
stimulated	O
genes	B:C0017337
in	O
response	O
to	O
IFN	O
-α	I:C0002199
stimulation	O
and	O
it	O
inhibits	O
the	O
antiproliferative	O
effect	O
of	O
IFN	O
-α	I:C0002199
on	O
latently	O
infected	O
BL	O
cells	I:C0004561
.	O

miR-BART16	O
abrogates	O
the	O
production	O
of	O
IFN	O
-	O
stimulated	O
genes	O
in	O
response	O
to	O
IFN	B:C0002199
-α	I:C0002199
stimulation	O
and	O
it	O
inhibits	O
the	O
antiproliferative	O
effect	O
of	O
IFN	O
-α	I:C0002199
on	O
latently	O
infected	O
BL	O
cells	I:C0004561
.	O

miR-BART16	O
abrogates	O
the	O
production	O
of	O
IFN	O
-	O
stimulated	O
genes	O
in	O
response	O
to	O
IFN	O
-α	I:C0002199
stimulation	B:C0038337
and	O
it	O
inhibits	O
the	O
antiproliferative	O
effect	O
of	O
IFN	O
-α	I:C0002199
on	O
latently	O
infected	O
BL	O
cells	I:C0004561
.	O

miR-BART16	O
abrogates	O
the	O
production	O
of	O
IFN	O
-	O
stimulated	O
genes	O
in	O
response	O
to	O
IFN	O
-α	I:C0002199
stimulation	O
and	O
it	O
inhibits	O
the	O
antiproliferative	B:C0003392
effect	O
of	O
IFN	O
-α	I:C0002199
on	O
latently	O
infected	O
BL	O
cells	I:C0004561
.	O

miR-BART16	O
abrogates	O
the	O
production	O
of	O
IFN	O
-	O
stimulated	O
genes	O
in	O
response	O
to	O
IFN	O
-α	I:C0002199
stimulation	O
and	O
it	O
inhibits	O
the	O
antiproliferative	O
effect	O
of	O
IFN	B:C0002199
-α	I:C0002199
on	O
latently	O
infected	O
BL	O
cells	I:C0004561
.	O

miR-BART16	O
abrogates	O
the	O
production	O
of	O
IFN	O
-	O
stimulated	O
genes	O
in	O
response	O
to	O
IFN	O
-α	I:C0002199
stimulation	O
and	O
it	O
inhibits	O
the	O
antiproliferative	O
effect	O
of	O
IFN	O
-α	I:C0002199
on	O
latently	O
infected	B:C0439663
BL	O
cells	I:C0004561
.	O

miR-BART16	O
abrogates	O
the	O
production	O
of	O
IFN	O
-	O
stimulated	O
genes	O
in	O
response	O
to	O
IFN	O
-α	I:C0002199
stimulation	O
and	O
it	O
inhibits	O
the	O
antiproliferative	O
effect	O
of	O
IFN	O
-α	I:C0002199
on	O
latently	O
infected	O
BL	B:C0004561
cells	I:C0004561
.	O

By	O
obstructing	O
the	O
type	B:C0021743
I	I:C0021743
IFN	I:C0021743
-	O
induced	O
antiviral	O
response	I:C1155328
,	O
miR-BART16	O
provides	O
a	O
means	O
to	O
facilitate	O
the	O
establishment	O
of	O
latent	O
EBV	O
infection	O
and	O
enhance	O
viral	O
replication	I:C0042774
.	O

By	O
obstructing	O
the	O
type	O
I	I:C0021743
IFN	I:C0021743
-	O
induced	O
antiviral	B:C1155328
response	I:C1155328
,	O
miR-BART16	O
provides	O
a	O
means	O
to	O
facilitate	O
the	O
establishment	O
of	O
latent	O
EBV	O
infection	O
and	O
enhance	O
viral	O
replication	I:C0042774
.	O

By	O
obstructing	O
the	O
type	O
I	I:C0021743
IFN	I:C0021743
-	O
induced	O
antiviral	O
response	I:C1155328
,	O
miR-BART16	B:C1101610
provides	O
a	O
means	O
to	O
facilitate	O
the	O
establishment	O
of	O
latent	O
EBV	O
infection	O
and	O
enhance	O
viral	O
replication	I:C0042774
.	O

By	O
obstructing	O
the	O
type	O
I	I:C0021743
IFN	I:C0021743
-	O
induced	O
antiviral	O
response	I:C1155328
,	O
miR-BART16	O
provides	O
a	O
means	O
to	O
facilitate	O
the	O
establishment	O
of	O
latent	O
EBV	B:C0014644
infection	O
and	O
enhance	O
viral	O
replication	I:C0042774
.	O

By	O
obstructing	O
the	O
type	O
I	I:C0021743
IFN	I:C0021743
-	O
induced	O
antiviral	O
response	I:C1155328
,	O
miR-BART16	O
provides	O
a	O
means	O
to	O
facilitate	O
the	O
establishment	O
of	O
latent	O
EBV	O
infection	B:C3714514
and	O
enhance	O
viral	O
replication	I:C0042774
.	O

By	O
obstructing	O
the	O
type	O
I	I:C0021743
IFN	I:C0021743
-	O
induced	O
antiviral	O
response	I:C1155328
,	O
miR-BART16	O
provides	O
a	O
means	O
to	O
facilitate	O
the	O
establishment	O
of	O
latent	O
EBV	O
infection	O
and	O
enhance	O
viral	B:C0042774
replication	I:C0042774
.	O

